#WeSupport

“WeSupport Health Complimentary Pharmacy Benefit” entitles applicants who received the Approved COVID-19 Vaccination to the free “WeGuard PharmaEASY Protector’s ”( the “Plan”) entry plan and the policy benefit term is one year( this “Promotion”).

This Promotion is offered by Blue Insurance Limited (the “Company”), effective from 8th April 2021 to 31st December 2021(both dates inclusive) (“Promotional Period”).

Eligibility (“Eligible Applicant”):

1. Hong Kong identity card holders with a residential address in Hong Kong; and

2. Aged between 18 and 65; and

3. Received the Approved COVID-19 Vaccination ; and

4. This Promotion is only applicable to customer who has never successfully applied for “WeGuard PharmaEASY Protector”

The “Approved COVID-19 Vaccination” shall mean the vaccination for the purpose of immunization against COVID-19 (not correlated to vaccines administered after the onset of infection), including the first dose, subsequent doses and booster doses, and must be approved by the United States Food and Drug Administration or health authorities of the government of the Hong Kong Special Administrative Region and prescribed by a Registered Medical Practitioner and administered by the same or a licensed or registered nurse of Hong Kong during the Promotional Period in Hong Kong.

“Registered Medical Practitioner” refers to a doctor with a recognised degree in western medicine who is duly registered and authorised to practise in Hong Kong.

Eligible applicant must successfully complete the application and payment, as illustrated in clause 12, for the Plan through the Company’s website within the Promotional Period.

This Promotion is subject to a limited quota for the first 1,000 Eligible Applicants within the Promotional Period.

Each Eligible Applicant can only enjoy this Promotion once.

This Promotion is only applicable to the premium during the first policy year of the Plan. Automatic renewal will be applied at the expiry of the benefit term and the policyholder is required to pay the second-year premium at a discounted price at HK$158. The policyholder is required to pay the premium at the original price for the third and following years upon policy renewal.

All policy provisions of the Plan remain unchanged. Please see the policy provisions for details.

This Promotion is only applicable to the policies issued in Hong Kong.

For this Promotion, the first year premium of the policy is HK$0. During the application process, HK$1 (the “Payment”) will be charged and rebated to the Eligible Applicant’s credit card for electronic direct debit authorization (the “eDDA”) purpose. The Payment is required to be paid by the policy applicant.

The Company reserves the right to amend the terms and conditions of this Promotion or discontinue them at any time without prior notice.

The above information is for general reference only. It shall not be construed as an offer to sell or a solicitation of an offer or recommendation to purchase or sale or provision of any products of the Company. Details of the Promotion of the Plan are subject to the policy provisions stipulated in the policy by the Company.

This Promotion is subject to these terms and conditions. The Company has the right to reject any applications. If there are any disputes, the Company's decision is final and conclusive.

Should there be any discrepancy between the English and Chinese versions, the English version shall prevail.

Details of “WeSupport Life Complimentary Compassionate Death Benefit”(this “Compassionate Death Benefit Coverage”):



This Compassionate Death Benefit Coverage is offered by Blue Insurance Limited (the “Company”), effective from 8th April 2021 to 31st December 2021(both dates inclusive)(“Promotional Period”).

“Existing policies” and “New policies” refer to all policies of the Designated Plans mentioned above that are in-force within the Promotional Period.

The “Approved COVID-19 Vaccination” shall mean the vaccination for the purpose of immunization against COVID-19 (not correlated to vaccines administered after the onset of infection), including the first dose, subsequent doses and booster doses, and must be approved by the United States Food and Drug Administration or health authorities of the government of the Hong Kong Special Administrative Region and prescribed by a Registered Medical Practitioner and administered by the same or a licensed or registered nurse of Hong Kong during the Promotional Period in Hong Kong.

“Covered Vaccination Adverse Reaction” shall mean a diagnosis of an Adverse Event Following Immunization (AEFI) within 14 days after receiving the Approved COVID-19 Vaccination.

“Adverse Event Following Immunization” (AEFI) shall mean any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the Approved COVID-19 Vaccination. AEFI shall carry the same meaning as defined by the World Health Organization. Source: World Health Organization website (accessed in Jan 2021): https://vaccine-safety-training.org/classification-of-aefis.html

“Registered Medical Practitioner” refers to a doctor with a recognised degree in western medicine who is duly registered and authorised to practise in Hong Kong.

Each person covered under this Compassionate Death Benefit Coverage will only be entitled to the benefit once despite the number of policies held by the customers with the Company.

All policy provisions of Designated Plans remain unchanged. Please see the policy provisions for details.

This Compassionate Death Benefit Coverage is only applicable to the policies issued in Hong Kong.

The Company reserves the right to amend the terms and conditions of this Compassionate Death Benefit Coverage or discontinue them at any time without prior notice.

The above information is for general reference only. It shall not be construed as an offer to sell or a solicitation of an offer or recommendation to purchase or sale or provision of any products of the Company. Details of the Compassionate Death Benefit Coverage of the Designated Plans are subject to the policy provisions stipulated in the policy by the Company.

This Compassionate Death Benefit Coverage is subject to these terms and conditions. The Company has the right to reject any applications. If there are any disputes, the Company's decision is final and conclusive.

Should there be any discrepancy between the English and Chinese versions, the English version shall prevail.

Designated Plans are provided by Blue Insurance Limited. (The Company). The Company is authorized and regulated by the Insurance Authority under the Insurance Ordinance (Cap.41) to sell insurance products in Hong Kong, and does not offer or sell any insurance products in any jurisdictions outside Hong Kong in which offering or sale of the insurance product is illegal under the laws of such jurisdictions.